Group 1 - The company Guangxi Huahong Pharmaceutical Group Co., Ltd. has applied for a "Type II meeting" with the CDE, which is currently in processing status [1] - Type II meetings are typically held within 60 days after application and are focused on critical issues during drug development, including pre-clinical trial meetings and risk assessment discussions [1] - Guangxi Huahong Pharmaceutical Group was established in 1982 and is primarily engaged in the pharmaceutical manufacturing industry, with a registered capital of 103 million RMB [1] Group 2 - The company has made investments in 10 enterprises and participated in 2,588 bidding projects [1] - It holds 318 trademark registrations and 233 patent registrations, along with 137 administrative licenses [1]